BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer

Chen Mao; Ru-Yan Liao; Qing Chen

首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer

【24h】

BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer

机译：BRAF突变预测在野生型KRAS转移性结直肠癌中对抗EGFR单克隆抗体的耐药性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Cancer Research and Clinical Oncology 》 |2010年第8期| p.1293-1294| 共2页
作者
Chen Mao; Ru-Yan Liao; Qing Chen;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer. [J] . Mao C, Liao RY, Chen Q Journal of Cancer Research and Clinical Oncology . 2010 ,第8期

机译：BRAF突变预测在野生型KRAS转移性结直肠癌中对抗EGFR单克隆抗体具有抗性。
2. PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis [J] . MaoC., YangZ.Y., HuX.F., Annals of oncology: official journal of the European Society for Medical Oncology . 2012 ,第6期

机译：PIK3CA外显子20突变作为KRAS野生型转移性结直肠癌中抗EGFR单克隆抗体耐药的潜在生物标志物：系统评价和荟萃分析
3. Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer [J] . A Rowland, M M Dias, M D Wiese, British Journal of Cancer . 2015 ,第12期

机译： BRAF 突变的荟萃分析作为抗EGFR单克隆抗体治疗 RAS 野生型转移性结直肠癌获益的预测生物标志物
4. Isolation of Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer Using Label-Free Microfluidic Technology for Enumeration and Detection of KRAS, BRAF, PIK3CA Mutation [C] . Haiyan Emily Liu, Evelyn Kidess-Sigal, Melanie Triboulet, International Molecular Medicine Tri-Conference. . 2016

机译：使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA，BRAF，PIK3CA突变
5. Glucose deprivation selects for KRAS and BRAF mutations in colorectal cancer. [D] . Yun, Jihye. 2009

机译：葡萄糖剥夺选择结直肠癌中的KRAS和BRAF突变。
6. Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer [O] . A Rowland, M M Dias, M D Wiese, 2015

机译：对BRAF突变的荟萃分析作为抗EGFR单克隆抗体治疗RAS野生型转移性结直肠癌获益的预测生物标志物
7. PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis [O] . C. Mao, Z.Y. Yang, X.F. Hu, 2012

机译：Pik3Ca Exon 20突变作为潜在的抗EGFR单克隆抗体在KRAS野生型转移性结肠直肠癌中的潜在生物标志物：系统审查和荟萃分析

BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer

著录项

相似文献

相关主题

期刊订阅